Yahoo Web Search

Search results

  1. Daphne Koller (Hebrew: דפנה קולר; born August 27, 1968) is an Israeli-American computer scientist. She was a professor in the department of computer science at Stanford University and a MacArthur Foundation fellowship recipient. She is one of the founders of Coursera, an online education platform.

    • August 27, 1968 (age 55), Israel
  2. Professor Daphne Koller Contact Information: home | biography | research | papers | my group courses | professional activities | FAQ | personal

  3. www.insitro.com › leadership › daphne-kollerDaphne Koller - insitro

    Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company transforming the way drugs are discovered and delivered to patients. She was the co-founder, co-CEO, and president of online education platform Coursera, the largest platform for massive open online courses (MOOCs), which has reached ...

  4. Daphne Koller is a professor of computer science and pathology at Stanford University. She has received many honors, including the MacArthur Foundation Fellowship, the ACM/Infosys Award, and the National Academy of Engineering membership.

  5. 3827. 2002. Support vector machine active learning with applications to text classification. S Tong, D Koller. Journal of machine learning research 2 (Nov), 45-66. , 2001. 3783. 2001. A gene-coexpression network for global discovery of conserved genetic modules.

  6. Nov 16, 2022 · Daphne Koller, founder and CEO of insitro, a company that uses AI to create better medicines, shares her vision and insights on how machine learning can transform drug discovery. Learn how insitro collects and analyzes data, identifies disease patterns, and tests therapeutic interventions with ML.

  7. Nov 3, 2020 · Daphne Koller is a veteran of the age of artificial intelligence and a leader in the use of machine learning to explore the causes and potential treatments for some serious diseases. She founded a company, insitro, that uses machine learning to help drug developers find new candidates. She shares her insights on the challenges and rewards of this field and the lessons she’s learned along the way.

  1. People also search for